Surface oxygen vacancy trigger peroxymonosulfate activation with cobalt modified montmorillonite for ofloxacin degradation: The synergistic effect of 1O2 and Co(IV)=O
Chinese Chemical Letters · 2026-06 · 37 (6) · 112112
DOI: 10.1016/j.cclet.2025.112112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-06. Verfasst von Xiao-qiang Cao und 10 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Natural Science Foundation of Qingdao Municipality, Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Natural Science Foundation of Qingdao Municipality
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Cao, X., Liu, X., Wang, Y., Wang, H., Wei, B., Shang, Y., Zhang, Y., Kan, Y., Zhang, Y., Xu, X., & Zhang, L. (2026). Surface oxygen vacancy trigger peroxymonosulfate activation with cobalt modified montmorillonite for ofloxacin degradation: The synergistic effect of 1O2 and Co(IV)=O. Chinese Chemical Letters, 37(6), 112112. https://doi.org/10.1016/j.cclet.2025.112112
Vancouver
Cao X, Liu X, Wang Y, Wang H, Wei B, Shang Y, et al. Surface oxygen vacancy trigger peroxymonosulfate activation with cobalt modified montmorillonite for ofloxacin degradation: The synergistic effect of 1O2 and Co(IV)=O. Chinese Chemical Letters. 2026;37(6):112112. doi:10.1016/j.cclet.2025.112112
BibTeX
@article{Cao2026,
author = {Cao, Xiao-qiang and Liu, Xingyao and Wang, Yaqi and Wang, Haining and Wei, Bo and Shang, Yanan and Zhang, Yizhen and Kan, Yujiao and Zhang, Yang and Xu, Xing and Zhang, Longlong},
title = {Surface oxygen vacancy trigger peroxymonosulfate activation with cobalt modified montmorillonite for ofloxacin degradation: The synergistic effect of 1O2 and Co(IV)=O},
journal = {Chinese Chemical Letters},
year = {2026},
volume = {37},
number = {6},
pages = {112112},
doi = {10.1016/j.cclet.2025.112112}
}
EUVIMED